Cargando…
Synthesis, docking and acetylcholinesterase inhibitory assessment of 2-(2-(4-Benzylpiperazin-1-yl)ethyl)isoindoline-1,3-dione derivatives with potential anti-Alzheimer effects
BACKGROUND: Alzheimer’s disease (AD) as neurodegenerative disorder, is the most common form of dementia accounting for about 50-60% of the overall cases of dementia among persons over 65 years of age. Low acetylcholine (ACh) concentration in hippocampus and cortex areas of the brain is one of the ma...
Autores principales: | Mohammadi-Farani, Ahmad, Ahmadi, Aram, Nadri, Hamid, Aliabadi, Alireza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704662/ https://www.ncbi.nlm.nih.gov/pubmed/23758724 http://dx.doi.org/10.1186/2008-2231-21-47 |
Ejemplares similares
-
2-(2-(4-Benzoylpiperazin-1-yl)ethyl)isoindoline-1,3-dione derivatives: Synthesis, docking and acetylcholinesterase inhibitory evaluation as anti-alzheimer agents
por: Mohammadi-Farani, Ahmad, et al.
Publicado: (2017) -
Synthesis and Evaluation of Anti-acetylcholinesterase Activity of 2-(2-(4-(2-Oxo-2-phenylethyl)piperazin-1-yl) ethyl)Isoindoline-1,3-dione Derivatives with Potential Anti-Alzheimer Effects
por: Aliabadi, Alireza, et al.
Publicado: (2013) -
Design, synthesis, and bio-evaluation of new isoindoline-1,3-dione derivatives as possible inhibitors of acetylcholinesterase
por: Hassanzadeh, Motahareh, et al.
Publicado: (2021) -
Phthalimide analogs as probable 15-lipoxygenase-1 inhibitors: synthesis, biological evaluation and docking studies
por: Aliabadi, Alireza, et al.
Publicado: (2015) -
2-[2-(Trimethylsilyl)ethyl]isoindoline-1,3-dione
por: Guzei, Ilia A., et al.
Publicado: (2009)